Open | $0.060 |
Close | $0.054 |
Volume / Avg. | 4.673M / 15.011M |
Day Range | 0.053 - 0.060 |
52 Wk Range | 0.044 - 1.400 |
Market Cap | $2.930M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 1.2% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sunshine Biopharma (NASDAQ: SBFM) through any online brokerage.
Other companies in Sunshine Biopharma’s space includes: Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Geovax Labs (NASDAQ:GOVX) and Finch Therapeutics Gr (NASDAQ:FNCH).
The latest price target for Sunshine Biopharma (NASDAQ: SBFM) was reported by Aegis Capital on Monday, August 7, 2023. The analyst firm set a price target for 2.60 expecting SBFM to rise to within 12 months (a possible 4732.71% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Sunshine Biopharma (NASDAQ: SBFM) is $0.0538 last updated March 18, 2024 at 7:46 PM EDT.
There are no upcoming dividends for Sunshine Biopharma.
Sunshine Biopharma’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Sunshine Biopharma.
Sunshine Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.